Lenire is a bimodal neuromodulation device combining sound and transmucosal electrical tongue stimulation to temporarily relieve the symptoms of tinnitus in patients ≥ 18 years of age with at least moderate tinnitus. Lenire therapy is intended to be self-administered by the patient following prescription by a healthcare professional who is experienced in the evaluation and management of tinnitus.
If you have a Hayes login, click here to view the full report on the Knowledge Center.